Akashdip, C.D., Dinesh, D.R., Paraag, S.G., 2010. Multiple Sclerosis & its Treatment with Alpha-Cobratoxin: A Review. Int J Pharmtech Res 2, 740-749.
Babaloo, Z., Yeganeh, R., Farhoudi, M., Baradaran, B., Bonyadi, M., Aghebati, L., 2013. Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis. Iran J Immunol 10, 47-54.
Batten, M., Li, J., Yi, S., Kljavin, N.M., Danilenko, D.M., Lucas, S., et al., 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7, 929-936.
Bettelli, E., Oukka, M., Kuchroo, V.K., 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8, 345-350.
Bidard, J.-N., Mourre, C., Lazdunski, M., 1987. Two potent central convulsant peptides, a bee venom toxin, the MCD peptide, and a snake venom toxin, dendrotoxin I, known to block K+ channels, have interacting receptor sites. Biochem Biophys Res Commun 143, 383-389.
Bielekova, B., Muraro, P.A., Golestaneh, L., Pascal, J., McFarland, H.F., Martin, R., 1999. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J Neuroimmunol 100, 115-123.
Bittner, S., Afzali, A.M., Wiendl, H., Meuth, S.G., 2014. Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice. J Vis Exp.
Bittner, S., Bauer, M.A., Ehling, P., Bobak, N., Breuer, J., Herrmann, A.M., et al., 2012. The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis. Exp Neurol 238, 149-155.
Cahalan, M.D., Wulff, H., Chandy, K.G., 2001. Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol 21, 235-252.
Calmette, A., Saenz, A., Costil, L., 1933. Effects du venin de cobra sur les greffes cancereuses et sur le cancer spontane (adeno-carcinome) de la souris. CR Acad Sci 197, 205-210.
Chen, X., Winkler-Pickett, R.T., Carbonetti, N.H., Ortaldo, J.R., Oppenheim, J.J., Howard, O.M., 2006. Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur J Immunol 36, 671-680.
Chiu, S.Y., Zhou, L., Zhang, C.L., Messing, A., 1999. Analysis of potassium channel functions in mammalian axons by gene knockouts. J Neurocytol 28, 349-364.
Diveu, C., McGeachy, M.J., Boniface, K., Stumhofer, J.S., Sathe, M., Joyce-Shaikh, B., et al., 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182, 5748-5756.
Ebrahim, K., Vatanpour, H., Zare, A., Shirazi, F.H., Nakhjavani, M., 2016. Anticancer Activity a of Caspian Cobra (Naja naja oxiana) snake Venom in Human Cancer Cell Lines Via Induction of Apoptosis. Iran J Pharm Res 15, 101-112.
Ferber, I.A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., et al., 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156, 5-7.
Fox, R.J., Bethoux, F., Goldman, M.D., Cohen, J.A., 2006. Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease. Cleve Clin J Med 73, 91-102.
Gao, H., Lee, B.N., Talpaz, M., Donato, N.J., Cortes, J.E., Kantarjian, H.M., et al., 2005. Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia. Leukemia 19, 1905-1911.
Handel, A.E., Lincoln, M.R., Ramagopalan, S.V., 2011. Of mice and men: experimental autoimmune encephalitis and multiple sclerosis. Eur J Clin Invest 41, 1254-1258.
Happel, K.I., Zheng, M., Young, E., Quinton, L.J., Lockhart, E., Ramsay, A.J., et al., 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 170, 4432-4436.
Herkert, M., Shakhman, O., Schweins, E., Becker, C.M., 2001. Beta-bungarotoxin is a potent inducer of apoptosis in cultured rat neurons by receptor-mediated internalization. Eur J Neurosci 14, 821-828.
Hofstetter, H.H., Shive, C.L., Forsthuber, T.G., 2002. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J Immunol 169, 117-125.
Judge, S.I., Bever, C.T., Jr., 2006. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Therapeut 111, 224-259.
Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., Altman, D.G., 2010. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS biology 8, e1000412.
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., et al., 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177, 566-573.
Lopez-Diego, R.S., Weiner, H.L., 2008. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary. Nature reviews. Drug discovery 7, 909-925.
McFarland, H.F., Martin, R., 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8, 913-919.
Mendel, I., Kerlero de Rosbo, N., Ben-Nun, A., 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 25, 1951-1959.
Newitt, R.A., Houamed, K.M., Rehm, H., Tempel, B.L., 1991. Potassium channels and epilepsy: evidence that the epileptogenic toxin, dendrotoxin, binds to potassium channel proteins. Epilepsy research. Supplement 4, 263-273.
Nishio, H., Inui, T., Nishiuchi, Y., De Medeiros, C.L., Rowan, E.G., Harvey, A.L., et al., 1998. Chemical synthesis of dendrotoxin-I: revision of the reported structure. J Pept Res 51, 355-364.
Okuda, Y., Okuda, M., Bernard, C.C., 2002. The suppression of T cell apoptosis influences the severity of disease during the chronic phase but not the recovery from the acute phase of experimental autoimmune encephalomyelitis in mice. J Neuroimmunol 131, 115-125.
Pakmanee, N., Khow, O., Kumsap, W., Omori-Satoh, T.,
Chanhome, L., Sriprapat, S., et al., 1998. Envenomation of mice by Thai Cobra (Naja kaouthia) venom: tolerable venom concentration and exposure time. Toxicon 36, 809-812.
Pot, C., Apetoh, L., Awasthi, A., Kuchroo, V.K., 2010. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J Interferon Cytokine Res 30, 381-388.
Rahn, E.J., Iannitti, T., Donahue, R.R., Taylor, B.K., 2014. Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus. Biol Sex Differ 5, 4.
Raine, C.S., 1984. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50, 608-635.
Rasband, M.N., Trimmer, J.S., Schwarz, T.L., Levinson, S.R., Ellisman, M.H., Schachner, M., et al., 1998. Potassium channel distribution, clustering, and function in remyelinating rat axons. J Neurosci 18, 36-47.
Rehm, H., Bidard, J.N., Schweitz, H., Lazdunski, M., 1988. The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels. Biochemistry 27, 1827-1832.
Reid, P.F., 2007. Alpha-cobratoxin as a possible therapy for multiple sclerosis: a review of the literature leading to its development for this application. Crit Rev Immunol 27, 291-302.
Ryan, M., McCarthy, L., Rappuoli, R., Mahon, B.P., Mills, K.H., 1998. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int Immunol 10, 651-662.
Schmidt, R.R., Betz, H., 1989. Cross-linking of beta-bungarotoxin to chick brain membranes. Identification of subunits of a putative voltage-gated K+ channel. Biochemistry 28, 8346-8350.
Sospedra, M., Martin, R., 2005. Immunology of multiple sclerosis. Annu Rev Immunol 23, 683-747.
Steinman, L., 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24, 511-514.
Vanderlugt, C.J., Miller, S.D., 1996. Epitope spreading. Curr Opin Immunol 8, 831-836.
Villarino, A.V., Huang, E., Hunter, C.A., 2004. Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 173, 715-720.
Wang, S., Miyazaki, Y., Shinozaki, Y., Yoshida, H., 2007.
Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J Immunol 179, 6421-6428.
Yoshimoto, T., Yoshimoto, T., Yasuda, K., Mizuguchi, J., Nakanishi, K., 2007. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol 179, 4415-4423.
Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H.L., Hafler, D.A., 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179, 973-984.
Zhao, Y., Huang, J., Yuan, X., Peng, B., Liu, W., Han, S., et al., 2015. Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases. Toxins 7, 1749-1764.
Zoë, F.-K., Abdolmohamad, R., Denise, C.F., 2010. Diverse and Opposing Roles of IL-27 in Immunity. Open Autoimmun J 2, 187-192.